Creutzfeldt–Jakob disease in a post-COVID-19 patient: did SARS-CoV-2 accelerate the neurodegeneration?

Autor:	Taha K. Alloush, Adel T. Alloush, Yaser Abdelazeem, Hossam M. Shokri, Khaled O. Abdulghani, Ahmed Elzoghby
Jazyk:	angličtina
Rok vydání:	2023
Předmět:	Sporadic Creutzfeldt–Jakob disease (sCJD) SARS-CoV-2 COVID-19 PET/MRI brain Neurodegenerative disorder Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571
Zdroj:	The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, Vol 59, Iss 1, Pp 1-7 (2023)
Druh dokumentu:	article
ISSN:	1687-8329
DOI:	10.1186/s41983-023-00666-y
Popis:	Abstract Background Creutzfeldt–Jakob disease (CJD) is a rare, fatal neurodegenerative disorder, with few months as a usual duration from onset to death. Case presentation In this case report, a patient of Sporadic CJD (sCJD) who presented one month after severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. The diagnosis of this case was established after confirming findings from clinical, neurophysiology, radiological, and laboratory features of this disease. Conclusion Putting in mind all the updated data on the pathogenesis of CJD and the immune responses to SARS-CoV-2, we can suggest that COVID-19 can lead to accelerated pathogenesis and exaggerated manifestations of this fatal neurodegenerative disease.
Databáze:	Directory of Open Access Journals
Externí odkaz:	https://doaj.org/article/b4a6ef6f92b44f53b771fa1ef0d563bf Zobrazit plný text záznamu View record in DOAJ Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.